Athira Pharma Inc. Stock Price, News, Quote & History

Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.

Athira Pharma Inc.

Athira Pharma Announces Reverse Stock Split

Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025

Athira Pharma to Participate in Upcoming June Conferences

Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action

Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Athira Pharma to Participate in Upcoming May Conferences

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

5 US Longevity and Anti-aging Stocks to Watch in 2025

ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results

Latest News

Drilling the Manindi Vanadium-Titanium-Magnetite Discovery

Altech - Service Data Confirms Exceptional Failure Rate

Sherritt Reports Third Quarter 2025 Results; Moa JV Expansion Complete; Phase Two Ramp Up Advancing

Alvopetro Announces Q3 2025 Financial Results and an Operational Update Including Record October Sales

Pfizer Responds to Delaware Chancery Court Ruling

Latest News

Outlook Reports world

Featured Biotech Investing Stocks

Browse Companies